Break Through Cancer launches a $15M multi-institute pediatric osteosarcoma research initiative

Population-based cancer surveillance is a national treasure at risk

There is a silent crisis in cancer research that underpins nearly all aspects of the work we do to combat this disease.

September 26, 2025

By Eric B. Durbin, Karen L. Knight, Betsy Kohler and Sarah Nash

Earlier diagnosis, better outcomes: Telemedicine has found a home in oncology

We are rapidly approaching the Sept. 30 planned expiration of telemedicine coverage under Medicaid. Letting this authorization expire is short-sighted. As an oncologist, I believe there are multiple compelling, non-pandemic reasons for telemedicine to remain a permanent fixture in cancer care.

Urgently needed: A funding mechanism to insulate cancer research from political whims

Jonathan Mahler’s article in the Sept. 14 issue of The New York Times Magazine provided an excellent overview of the Trump administration’s assault on cancer research.

AACR survey finds overwhelming public support for federal funding for medical and cancer research

The American Association for Cancer Research released the results of a national survey measuring voters’ attitudes about federal funding for medical research, which found very high levels of support for federal funding for medical and cancer research across the electorate.

September 19, 2025

Vol.51 No.34

By Claire Marie Porter

In Brief

Casey Graves appointed general manager of clinical solutions at ConcertAI

ConcertAI named Casey Graves general manager of Clinical Solutions. In this role, Graves will drive growth and innovation in real-world data and AI solutions for oncology research and clinical care, accelerating advances that improve outcomes for patients and healthcare providers.

September 19, 2025

Vol.51 No.34